1. Home
  2. Browse
  3. Drug Information

Drug Information

1186 - 1200 of 1907 Results
Sort Results:
Guideline: CDA Clinical Practice Guidelines on Monitoring Glycemic Control (2008) July 2008
Guideline: Treating Tobacco Use and Dependence: 2008 Update July 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 July 2008
Guideline: Worldwide Standardization of the Hemoglobin A1C Measurement (2007) July 2008
Article: Patanase (olopatadine) and Omnaris (ciclesonide) nasal sprays for allergic rhinitis June 2008
Guideline: Management of Acute Migraine Attacks (US Headache Consortium) (2000) June 2008
Commentary: New Drug: Cimzia (Certolizumab Pegol) June 2008
Commentary: New Formulation: Treximet (Sumatriptan and Naproxen) for Migraine June 2008
Commentary: Omnaris (Ciclesonide) and Patanase (Olopatadine): New Nasal Sprays for Allergic Rhinitis June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Guideline: Perianal Crohn’s Disease (2003) June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Prevention of Migraine (US Headache Consortium) (2000) June 2008
Guideline: Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache (AAFP/ACP-ASIM) (2002) June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008